-- 獨立研究機構CFRA向提供了以下研究報告。 CFRA分析師總結如下:EOG公佈的第一季調整後每股收益為3.41美元,高於市場預期的2.87美元,超出預期0.20美元。產量飆升27%至138萬桶油當量/日,其中天然氣產量增加45%至30.2億立方英尺/日,液化天然氣產量增加37%,主要得益於以44.5億美元完成的Encino收購案。該收購案預計將於2025年第三季完成,將擴大EOG在尤蒂卡頁岩氣領域的佈局。我們認為這項具有變革意義的交易將增強EOG的資產組合和成長勢頭,但成本壓力也顯而易見,集輸和運輸費用成長49%至6.54億美元,反映出營運整合的挑戰。天然氣價格上漲10%至3.76美元/百萬英熱單位,而原油價格持平於72.47美元/桶。儘管資本支出增加至16.4億美元,EOG的自由現金流仍維持強勁,達到14.9億美元。 EOG的淨債務增加至40.8億美元,淨債務佔總資本的比率為11.7%。我們注意到,這一比率遠低於我們勘探開發同行25%的平均水平,這為EOG提供了財務靈活性,同時我們認為,EOG也從其不斷擴大的資產基礎中獲得了巨大的成長潛力。
Related Articles
Simcere Pharmaceutical Receives Chinese Regulatory Approval to Begin Trials of Tumor Drug
Simcere Pharmaceutical (HKG:2096) received Chinese regulatory approval to begin clinical trials of SIM0613, according to a Hong Kong bourse filing Wednesday.The injection is intended to treat advanced solid tumors and is licensed to Ipsen Pharma in regions outside Greater China.
Meitu Records 30% Rise in Paying Subscribers
Meitu (HKG:1357) said the number of paying subscribers using its platform grew 30% year on year to 17.90 million as of end March, according to a Hong Kong bourse filing Wednesday.Paying subscribers for the company's productivity tools grew 53% to 2.34 million, while leisure app subscribers increased 27% to 15.56 million, the firm said.The company's core revenue grew 34.3% year on year to 852 million yuan, while other businesses remained "stable overall."The company's annual recurring revenue for AI-driven productivity apps stood at 580 million yuan as of March, a 56% increase from a year earlier.
Yidu Tech Unit Wins SG$2.3 Million Singapore Healthcare Project
Yidu Tech (HKG:2158) said its subsidiary EVYD Research Private Limited won a contract from Singapore Health Services for the implementation and support of Dr Buddy, according to a Wednesday Hong Kong bourse filing.The total project amount is about SG$2.3 million.